301 related articles for article (PubMed ID: 34071546)
21. RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.
Cailliau K; Lescuyer A; Burnol AF; Cuesta-Marbán Á; Widmann C; Browaeys-Poly E
J Biol Chem; 2015 Aug; 290(32):19653-65. PubMed ID: 26109071
[TBL] [Abstract][Full Text] [Related]
22. Proliferation of neointimal smooth muscle cells after arterial injury. Dependence on interactions between fibroblast growth factor receptor-2 and fibroblast growth factor-9.
Agrotis A; Kanellakis P; Kostolias G; Di Vitto G; Wei C; Hannan R; Jennings G; Bobik A
J Biol Chem; 2004 Oct; 279(40):42221-9. PubMed ID: 15292181
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor receptor 3 induces gene expression primarily through Ras-independent signal transduction pathways.
Choi DY; Toledo-Aral JJ; Lin HY; Ischenko I; Medina L; Safo P; Mandel G; Levinson SR; Halegoua S; Hayman MJ
J Biol Chem; 2001 Feb; 276(7):5116-22. PubMed ID: 11084019
[TBL] [Abstract][Full Text] [Related]
24. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.
Francavilla C; Loeffler S; Piccini D; Kren A; Christofori G; Cavallaro U
J Cell Sci; 2007 Dec; 120(Pt 24):4388-94. PubMed ID: 18042627
[TBL] [Abstract][Full Text] [Related]
25. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
26. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 correlates with the perinuclear association of the FGF receptor-1alpha isoforms but not the FGF receptor-1beta isoforms.
Prudovsky IA; Savion N; LaVallee TM; Maciag T
J Biol Chem; 1996 Jun; 271(24):14198-205. PubMed ID: 8662999
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor signaling in Caenorhabditis elegans.
Borland CZ; Schutzman JL; Stern MJ
Bioessays; 2001 Dec; 23(12):1120-30. PubMed ID: 11746231
[TBL] [Abstract][Full Text] [Related]
28. Translocated in liposarcoma (TLS) is a substrate for fibroblast growth factor receptor-1.
Klint P; Hellman U; Wernstedt C; Aman P; Ron D; Claesson-Welsh L
Cell Signal; 2004 Apr; 16(4):515-20. PubMed ID: 14709340
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
Brooks AN; Kilgour E; Smith PD
Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
[TBL] [Abstract][Full Text] [Related]
31. Downstream-of-FGFR is a fibroblast growth factor-specific scaffolding protein and recruits Corkscrew upon receptor activation.
Petit V; Nussbaumer U; Dossenbach C; Affolter M
Mol Cell Biol; 2004 May; 24(9):3769-81. PubMed ID: 15082772
[TBL] [Abstract][Full Text] [Related]
32. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development.
Li C; Scott DA; Hatch E; Tian X; Mansour SL
Development; 2007 Jan; 134(1):167-76. PubMed ID: 17164422
[TBL] [Abstract][Full Text] [Related]
33. Nuclear Fibroblast Growth Factor Receptor Signaling in Skeletal Development and Disease.
Tuzon CT; Rigueur D; Merrill AE
Curr Osteoporos Rep; 2019 Jun; 17(3):138-146. PubMed ID: 30982184
[TBL] [Abstract][Full Text] [Related]
34. Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts.
Kontaridis MI; Liu X; Zhang L; Bennett AM
Mol Cell Biol; 2002 Jun; 22(11):3875-91. PubMed ID: 11997521
[TBL] [Abstract][Full Text] [Related]
35. Small molecule inhibition of fibroblast growth factor receptors in cancer.
Liang G; Chen G; Wei X; Zhao Y; Li X
Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
[TBL] [Abstract][Full Text] [Related]
36. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
37. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
[TBL] [Abstract][Full Text] [Related]
38. FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14.
Novoyatleva T; Sajjad A; Pogoryelov D; Patra C; Schermuly RT; Engel FB
FASEB J; 2014 Jun; 28(6):2492-503. PubMed ID: 24571920
[TBL] [Abstract][Full Text] [Related]
39. Signaling, internalization, and intracellular activity of fibroblast growth factor.
Wiedłocha A; Sørensen V
Curr Top Microbiol Immunol; 2004; 286():45-79. PubMed ID: 15645710
[TBL] [Abstract][Full Text] [Related]
40. Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning.
Celli G; LaRochelle WJ; Mackem S; Sharp R; Merlino G
EMBO J; 1998 Mar; 17(6):1642-55. PubMed ID: 9501086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
